| Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies DJ DeAngelo, A Spencer, KN Bhalla, HM Prince, T Fischer, T Kindler, ... Leukemia 27 (8), 1628, 2013 | 154 | 2013 |
| Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma JF San-Miguel, PG Richardson, A Günther, O Sezer, D Siegel, J Bladé, ... Journal of clinical oncology 31 (29), 3696-3703, 2013 | 151 | 2013 |
| A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer DE Rathkopf, J Picus, A Hussain, S Ellard, KN Chi, T Nydam, ... Cancer chemotherapy and pharmacology 72 (3), 537-544, 2013 | 93 | 2013 |
| Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage … GE Konecny, N Finkler, AA Garcia, D Lorusso, PS Lee, RP Rocconi, ... The Lancet Oncology 16 (6), 686-694, 2015 | 92 | 2015 |
| Design and performance of a thermal neutron imaging facility at the North Carolina State University PULSTAR reactor KK Mishra, AI Hawari, VH Gillette IEEE transactions on nuclear science 53 (6), 3904-3911, 2006 | 45 | 2006 |
| Ceritinib plus nivolumab (NIVO) in patients (pts) with anaplastic lymphoma kinase positive (ALK+) advanced non-small cell lung cancer (NSCLC). E Felip, FG De Braud, M Maur, HHF Loong, AT Shaw, JF Vansteenkiste, ... Journal of Clinical Oncology 35 (15_suppl), 2502-2502, 2017 | 42 | 2017 |
| Accurate simulation of thermal neutron filter effects in the design of research reactor beam applications AI Hawari, II Al-Qasir, KK Mishra PHYSOR-2006: Advances in Nuclear Analysis and Simulation, 2006 | 18 | 2006 |
| Asciminib, a Specific Allosteric BCR-ABL1 Inhibitor, in Patients with Chronic Myeloid Leukemia Carrying the T315I Mutation in a Phase 1 Trial D Rea, F Lang, DW Kim, JE Cortes, TP Hughes, H Minami, M Breccia, ... Blood 132 (Suppl 1), 792-792, 2018 | 11 | 2018 |
| Development of a thermal neutron imaging facility at the NC State University PULSTAR reactor KK Mishra | 10 | 2005 |
| Investigation of coded source neutron imaging at the North Carolina State University PULSTAR reactor Z Xiao, KK Mishra, AI Hawari, HZ Bilheux, PR Bingham, KW Tobin 2009 IEEE Nuclear Science Symposium Conference Record (NSS/MIC), 1289-1294, 2009 | 8 | 2009 |
| LBA27PHASE 2 STUDY OF SECOND-LINE DOVITINIB (TKI258) IN PATIENTS WITH FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2)-MUTATED OR-NONMUTATED ADVANCED AND/OR METASTATIC ENDOMETRIAL … GE Konecny, N Finkler, AA Garcia, D Lorusso, P Lee, R Rocconi, ... Annals of Oncology 25 (suppl_4), 2014 | 7 | 2014 |
| Coded source neutron imaging at the PULSTAR reactor Z Xiao, KK Mishra, AI Hawari, PR Bingham, HZ Bilheux, KW Tobin Nuclear Instruments and Methods in Physics Research Section A: Accelerators …, 2011 | 5 | 2011 |
| Combination of Asciminib+ Nilotinib or Asciminib+ Dasatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results DJ DeAngelo, MJ Mauro, DW Kim, J Cortes, D Réa, TP Hughes, H Minami, ... Clinical Lymphoma, Myeloma and Leukemia 19, S290-S291, 2019 | 4* | 2019 |
| Combination of Asciminib, a Novel and Specific BCR-ABL1 Inhibitor, Plus Imatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results M Talpaz, J Cortes, F Lang, DW Kim, D Réa, MJ Mauro, H Minami, ... Clinical Lymphoma, Myeloma and Leukemia 19, S287-S288, 2019 | 3 | 2019 |
| Phase contrast neutron imaging at the PULSTAR reactor KK Mishra, AI Hawari Nuclear Instruments and Methods in Physics Research Section A: Accelerators …, 2011 | 3 | 2011 |
| Estimation of SCRAM Rate Trends in Nuclear Power Plants Using Hierarchical Bayes Models KK Mishra, SK Ghosh Communications in Statistics—Theory and Methods 38 (16-17), 2856-2871, 2009 | 2 | 2009 |
| Investigating Phase Contrast Neutron Imaging for Mixed Phase-Amplitude Objects KK Mishra, AI Hawari IEEE Transactions on Nuclear Science 56 (3), 1629-1636, 2009 | 2 | 2009 |
| Phase contrast neutron imaging at a medium intensity neutron source KK Mishra, AI Hawari 2009 IEEE Nuclear Science Symposium Conference Record (NSS/MIC), 1283-1288, 2009 | 2 | 2009 |
| COMBINATION THERAPY USING ASCIMINIB PLUS IMATINIB (IMA) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 1 STUDY: S883 J Cortes, F Lang, DW Kim, D Réa, MJ Mauro, H Minami, M Breccia, ... HemaSphere 3, 397, 2019 | 1 | 2019 |
| Phase Contrast Neutron Imaging using Single and Multiple Pinhole Apertures KK Mishra North Carolina State University, 2010 | 1 | 2010 |
